The Board of Directors of Cannara Biotech Inc. has authorized a buyback plan on November 11, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.77 CAD | -4.94% | +1.32% | -7.23% |
1st Jan change | Capi. | |
---|---|---|
-7.23% | 5.33Cr | |
-.--% | 34Cr | |
+38.14% | 28Cr | |
+41.98% | 27Cr | |
+46.51% | 19Cr | |
+156.53% | 15Cr | |
-36.93% | 13Cr | |
+19.23% | 10Cr | |
-42.86% | 9.67Cr | |
+8.62% | 5.74Cr |
- Stock Market
- Equities
- LOVE Stock
- News Cannara Biotech Inc.
- Cannara Biotech Inc. authorizes a Buyback Plan.